For those that follow this blog, I once wrote about an asset class known as business development companies, particularly middle-market lending BDCs. These businesses typically concentrate on investing through the financing of middle-market private equity transactions.[More...]
For those that follow this blog, I once wrote about an asset class known as business development companies, particularly middle-market lending BDCs. These businesses typically concentrate on investing through the financing of middle-market private equity transactions. Over the last year, some have come under pressure as a result of government ...
var fbShare = {url: 'http://ceoworld.biz/ceo/2009/10/27/ares-capital-to-acquire-lender-allied-capital-for-648m/',size:'large'}Ares Capital Corp. (ARCC) announced plans to acquire fellow lender Allied Capital Corp. (ALD) for $648 million in stock as Ares plans to be a consolidator in the space.
Meanwhile, Ares projected third-quarter earnings of 35 cents to 36 cents a share; the average estimate of analysts surveyed by [...]
American Capital (ACAS) received proceeds of $400 million with the sale of its portfolio company Axygen BioScience Inc. ? including its subsidiaries Axygen Inc. and Sorenson BioScience Inc. ? to Corning Incorporated on Sep 15.
American Capital invested in the One Stop Buyout™ of Axygen Inc. in September 2006. It invested in debt and equity of [...]
Standard and Poor’s Rating Services (S&P) recently downgraded American Capital’s (ACAS) long-term counterparty credit rating to “B-” from “BB-”. The outlook is negative. S&P expressed concern about the rapid decline in the company’s realized earnings, debts and the deteriorating performance of its portfolio companies.
American Capital has been significantly hurt by the financial downturn. It reported [...]
Get daily news and insights for the advertising, automotive, energy, financial services, food, health care, media, pharmaceutical, retail, technology, and travel industries.
